Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry. New England Biolabs (NEB) is now a recognized world leader in the discovery, development and commercialization of recombinant and native enzymes for genomic research. NEB offers the largest selection of recombinant and native enzymes for genomic research as well as products related to PCR, gene expression, cellular analysis, RNA analysis and epigenetics.
